S423-0813 Screening compound: 1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one

S423-0813 Screening compound: 1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one
S423-0813 Screening compound: 1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S423-0813
1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S423-0813

Molecular Formula

C20H29NO3 (C20 H29 NO3)

Compound Name

1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one

IUPAC name

1-{4-ethoxy-1-oxa-9-azaspiro[5.5]undecan-9-yl}-2-(3-methylphenyl)ethan-1-one

SMILES

CCOC1CC(CC2)(CCN2C(Cc2cc(C)ccc2)=O)OCC1

InChI

InChI=1S/C20H29NO3/c1-3-23-18-7-12-24-20(15-18)8-10-21(11-9-20)19(22)14-17-6-4-5-16(2)13-17/h4-6,13,18H,3,7-12,14-15H2,1-2H3/t18-/m1/s1

InChI Key

NJUIRLOKZWJXGS-GOSISDBHSA-N

MDL Number (MFCD)

MFCD31986124

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

331.46

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.938

Distribution Coefficient, logD

2.938

Water Solubility, LogSw

-3.05

Polar Surface Area

29.599

Acid Dissociation Constant (pKa)

18.21

Base Dissociation Constant (pKb)

-0.31

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.00

S423-0813 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S423-0813 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S423-0813?
Check Price and Availability of S423-0813, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S423-0813 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S423-0813
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S423-0813
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S423-0813 available by request